StockDuty ← Dashboard Aug 26, 2026 07:58 PM ET
CatalystFDA/Bio

REVOLUTION MEDICINES GETS FDA NOD FOR TARGETED PANCREATIC CANCER DRUG - CNBC

FDA approval catalyst for targeted pancreatic cancer drug validates clinical progress.

What changed
Why it matters
FDA approval catalyst for targeted pancreatic cancer drug validates clinical progress.
Sources
cnbc
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →